George K Ng
Director; Director, Chief Executive Officer · 13 filings · Latest: Aug 8, 2026
Processa Pharmaceuticals, Inc.
TuHURA Biosciences, Inc./NV
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PCSA | George K Ng | Director, Chief Executive Officer | Aug 8, 2026 | Option Exercise | — | 1,600 | — | 17,092 | |
PCSA | George K Ng | Director, Chief Executive Officer | Jul 1, 2026 | Purchase | $1.93 | 3,057 | $5.9K | 15,492 | |
PCSA | George K Ng | Director, Chief Executive Officer | Jun 15, 2026 | Purchase | $2.22 | 2,465 | $5.5K | 12,435 | |
PCSA | George K Ng | Director, Chief Executive Officer | May 29, 2026 | Purchase | $2.57 | 2,129 | $5.5K | 9,970 | |
PCSA | George K Ng | Director, Chief Executive Officer | May 15, 2026 | Purchase | $2.97 | 1,843 | $5.5K | 7,841 | |
PCSA | George K Ng | Director, Chief Executive Officer | Apr 15, 2026 | Purchase | $2.97 | 1,843 | $5.5K | 3,979 | |
PCSA | George K Ng | Director, Chief Executive Officer | Apr 30, 2026 | Purchase | $2.69 | 2,034 | $5.5K | 6,013 | |
PCSA | George K Ng | Director, Chief Executive Officer | Apr 15, 2026 | Purchase | $2.97 | 1,843 | $5.5K | 3,979 | |
PCSA | George K Ng | Director, Chief Executive Officer | Mar 31, 2026 | Purchase | $2.54 | 2,136 | $5.4K | 2,136 | |
PCSA | George K Ng | Director, Chief Executive Officer | Apr 15, 2026 | Purchase | $2.97 | 1,843 | $5.5K | 5,492 | |
PCSA | George K Ng | Director, Chief Executive Officer | Mar 31, 2026 | Purchase | $2.54 | 2,136 | $5.4K | 3,649 |